DBA is the paid Founding Director and Chief Executive Officer of the Ellison Institute for Transformative Medicine, a public good for-profit (the Institute comprises both a for-profit entity, whose profits will be reinvested into future public health and disease research, as well as a not-for-profit research foundation), which draws collaborators from across conventional health fields, as well as from a broad range of other disciplines to study disease and potential ways to prevent, detect, and treat the disease, and is a paid faculty member of the University of Southern California. JB is a paid faculty member of Oxford University, a paid Non-Executive Director of Oxford Science Enterprises, an independent investment company that has active investments in life sciences (novel platforms, technologies, and approaches advancing the discovery of new therapeutics and vaccines), health tech (medical devices, tools, digital diagnostics, AI-powered clinical imaging, virtual reality therapy, and solutions to improve health-care delivery), and deep tech (quantum computing and enabling technologies, fusion energy, industrial heat, novel computer hardware, electrified transportation, and solutions to tackle depleting food resources), and is a paid Chair of the Bill & Melinda Gates Foundation's Global Health Scientific Advisory Board. DBA and JB are non-paid Co-Chairs of the Global Health Security Consortium, a partnership to support and guide leaders on the global health security agenda. AN is a paid Special Adviser to Gavi, the Vaccine Alliance. We declare no other competing interests.